You haven't searched anything yet.
Are you passionate about being a critical part of the innovative biotech industry in an IR consulting capacity? If so, this is an exciting opportunity to work with a team with a long track record of providing best-in-class investor relations counsel to leaders across biotech and healthcare.
Stern Investor Relations, Inc., a Precision Medicine Group Company, is a well-established leader in providing IR services to biotechnology and healthcare companies, representing public and private companies of all sizes and therapeutic areas. In collaborating with our clients on their larger corporate strategy, we provide a range of services to achieve key investor relations goals, including effective messaging and positioning, enhancing visibility, improving institutional ownership and sell-side coverage, preparing for financings and IPOs, developing good guidance practices and managing communications around M&A, binary events and other strategic issues.
We are growing and are seeking investor relations professionals to further build our practice. We are pleased to offer a hybrid opportunity from our office in New York City, the center of the investment universe!
What you can expect day-to-day:
A successful Analyst candidate will help to advance Stern IR’s mission to provide best-in-class, thought-leading investor relations counsel to biotechnology and healthcare companies. You will work closely with senior account leads in an agency setting to manage client engagements, build and execute investor relations programs focusing on strategic advice and tactical execution, track sector trends and gather and analyze data and plan client events, while supporting the larger business through various initiatives directed towards clients and industry leadership.
Responsibilities include:
Qualifications:
Preferred:
About Us:
Stern Investor Relations, Inc., is a leading provider of investor relations services to entrepreneurial healthcare and biotechnology companies. Precision Medicine Group is a leading services provider to innovative life sciences companies, focused on supporting global companies in next-generation approaches to drug development and commercialization.
Full Time
$115k-160k (estimate)
03/14/2024
05/13/2024
sternir.com
New York, NY
50 - 100